2-hydroxybenzylamine for the prevention of alzheimer's disease: initial evaluation in humans

Ended Project Grant Awarded Last action

Award ID
R44AG055184
Recipient
Awarding agency
Obligated
$1,506,752

Award facts

Assistance listing
93.866 Aging Research
Completion date
Originally
Place of performance
Iowa, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment -$150,636
Amendment $150,636
Amendment $0
Amendment $0
Amendment $605,216
Amendment -$605,216
Amendment $605,216
Amendment $0
Amendment -$605,216
Amendment $150,636
Amendment $683,637
Original award $672,479
Show all 17

Quick answers

Who received award R44AG055184?

R44AG055184 was awarded to MTI Biotech, Incorporated by National Institute on Aging (National Institutes of Health) on September 30, 2016.

How much is award R44AG055184 worth?

$1,506,752 has been obligated on R44AG055184.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award